As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...
Of the top 20, Novo and Lilly were among only six companies that witnessed declines in their market value in the third ...
Insider Monkey on MSN9d
Is Bristol-Myers Squibb Company (BMY) the Best Pharma Stock to Buy Right Now?We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at ...
Bristol Myers Squibb (NYSE: BMY) recently reported its Q3 results, with revenues and earnings exceeding the street estimates.
Leerink upgrades Bristol-Myers Squibb with an increased price target and strong sales projections for Cobenfy and milvexian, ...
We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against the other ...
The global biopharmaceutical market saw a 2% increase in market capitalization in Q3 2024, led by growth from Bristol-Myers ...
The Big Pharma companies made a last-ditch effort asking a U.S. appeals court to reconsider their lawsuits against the ...
Pharmaceutical giant Bristol Myers Squibb (BMY) raises its full-year earnings guidance after topping third quarter estimates, ...
Concluded targeted enrollment of Phase 3 INDIGO trial evaluating obexelimab for the treatment of Immunoglobulin G4-Related ...
Negative data cost AbbVie billions of dollars in market value and convinced analysts Bristol Myers had placed a better bet in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback